Efinaconazole
Brand name: Jublia
Rank #422 of 500 drugs by total cost
$20.4M
Total Cost
15,425
Total Claims
$20.4M
Total Cost
576
Prescribers
$1,321
Cost per Claim
1,996
Beneficiaries
17,124
30-Day Fills
$35K
Avg Cost/Provider
27
Avg Claims/Provider
About Efinaconazole
Efinaconazole (sold as Jublia) was prescribed 15,425 times by 576 Medicare Part D providers in 2023, costing the program $20.4M. At $1,321 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 419 | Insulin Pump Cart,cont Inf,bt (Omnipod Dash Pods (Gen 4)) | $20.9M | 16,219 |
| 420 | Ziprasidone Hcl (Ziprasidone Hcl) | $20.8M | 239,041 |
| 421 | Sodium, Potassium,mag Sulfates (Sod Sulf-Potass Sulf-Mag Sulf) | $20.7M | 246,742 |
| 422 | Efinaconazole (Jublia) | $20.4M | 15,425 |
| 423 | Mometasone/Formoterol (Dulera) | $20.4M | 46,961 |
| 424 | Brinzolamide (Azopt) | $20.1M | 57,322 |
| 425 | Clobazam (Clobazam) | $19.8M | 58,877 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology